Next Article in Journal / Special Issue
Identification of Marine Neuroactive Molecules in Behaviour-Based Screens in the Larval Zebrafish
Previous Article in Journal
Violapyrones H and I, New Cytotoxic Compounds Isolated from Streptomyces sp. Associated with the Marine Starfish Acanthaster planci
Previous Article in Special Issue
Quorum Quenching Agents: Resources for Antivirulence Therapy
Mar. Drugs 2014, 12(6), 3292-3306; doi:10.3390/md12063292

The Protective Effect of Fucoidan in Rats with Streptozotocin-Induced Diabetic Nephropathy

1,* , 1,3,4
1 Institute of Oceanology, Chinese Academy of Sciences, Qingdao 266071, China 2 School of Life Sciences, Nantong University, Seyuan Road 9, Nantong 226019, China 3 Nantong Branch, Institute of Oceanology, Chinese Academy of Sciences, Nantong, Jiangsu 226006, China 4 Collaborative Innovation Center for Marine Biomass Fibers, Materials and Textiles of Shandong Province, Qingdao 266071, China
* Author to whom correspondence should be addressed.
Received: 18 February 2014 / Revised: 9 May 2014 / Accepted: 9 May 2014 / Published: 30 May 2014
(This article belongs to the Special Issue Advances and New Perspectives in Marine Biotechnology)
View Full-Text   |   Download PDF [1555 KB, uploaded 24 February 2015]   |   Browse Figures


Diabetic nephropathy (DN) has long been recognized as the leading cause of end-stage renal disease, but the efficacy of available strategies for the prevention of DN remains poor. The aim of this study was to investigate the possible beneficial effects of fucoidan (FPS) in streptozotocin (STZ)-induced diabetes in rats. Wistar rats were made diabetic by injection of STZ after removal of the right kidney. FPS was administered to these diabetic rats for 10 weeks. Body weight, physical activity, renal function, and renal morphometry were measured after 10 weeks of treatment. In the FPS-treated group, the levels of blood glucose, BUN, Ccr and Ucr decreased significantly, and microalbumin, serum insulin and the β2-MG content increased significantly. Moreover, the FPS-treated group showed improvements in renal morphometry. In summary, FPS can ameliorate the metabolic abnormalities of diabetic rats and delay the progression of diabetic renal complications.
Keywords: sulfated polysaccharide; fucoidan; diabetic nephropathy sulfated polysaccharide; fucoidan; diabetic nephropathy
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Share & Cite This Article

Further Mendeley | CiteULike
Export to BibTeX |
MDPI and ACS Style

Wang, J.; Liu, H.; Li, N.; Zhang, Q.; Zhang, H. The Protective Effect of Fucoidan in Rats with Streptozotocin-Induced Diabetic Nephropathy. Mar. Drugs 2014, 12, 3292-3306.

View more citation formats

Related Articles

Article Metrics

For more information on the journal, click here


Cited By

[Return to top]
Mar. Drugs EISSN 1660-3397 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert